Join to access to all OVN content. Join for Free
Motivation Means NOTHING…
Medical Science Liaisons discipline in Medical Affairs achieving goals personal growth strategies success in MSL roles

Motivation Means NOTHING…


Share This Article


Summary

In this episode, Tom Caravela delves into the crucial role of discipline for Medical Science Liaisons. He outlines a four-step process to help MSLs achieve their goals within Medical Affairs, emphasizing the importance of starting small and maintaining a zero-compromise mentality. Tom underscores the significance of discipline in driving success and personal growth. The episode wraps up with a call to action, inviting listeners to incorporate these strategies into their professional lives.

This SOLO episode features Tom Caravela, Managing Partner at The Carolan Group sharing his thoughts on WHY motivation means NOTHING and what it takes to find success and achieve your goals
Tom shares….

👉 WHY motivations means nothing
👉 What it takes to find consistent success
👉 The formula for consistency
👉 How to ACHIEVE and find success at the highest levels

Click for Source
Medical Science Liaisons, discipline in Medical Affairs, achieving goals, personal growth strategies, success in MSL roles

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Explore OVN